ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
449 |
138K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
449 |
138K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
449 |
138K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
449 |
138K |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
449 |
138K |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
449
|
138K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
449 |
138K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
449
|
138K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
449 |
138K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
449
|
138K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
449 |
138K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
449
|
138K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
JB1975
|
449 |
138K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
449
|
138K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
JB1975
|
2.1K |
666K |
9 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
2.1K
|
666K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
58 |
9.3K |
3 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
58
|
9.3K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
58 |
9.3K |
1 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
58
|
9.3K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
58 |
9.3K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
58
|
9.3K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
58 |
9.3K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
58
|
9.3K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
58 |
9.3K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
58
|
9.3K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
58 |
9.3K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
58
|
9.3K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
58 |
9.3K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
58
|
9.3K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
JB1975
|
58 |
9.3K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
58
|
9.3K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
2.8K |
1 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
19
|
2.8K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
2.8K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
19
|
2.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
JB1975
|
154 |
43K |
6 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
43K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
2.8K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
19
|
2.8K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
2.8K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
19
|
2.8K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
2.8K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
19
|
2.8K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
2.8K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
19
|
2.8K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
The Phase I/IIb Nereid Study Is Now Registered
|
|
JB1975
|
19 |
2.8K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
19
|
2.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
4 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
5 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
8 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
JB1975
|
362 |
115K |
2 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
362
|
115K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
JB1975
|
362 |
115K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
362
|
115K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
JB1975
|
362 |
115K |
5 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
362
|
115K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
JB1975
|
362 |
115K |
2 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
362
|
115K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
5 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
6 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
2 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
6 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
9 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
5 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
JB1975
|
9.2K |
2.6M |
6 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
JB1975
|
512 |
122K |
4 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
512
|
122K
|
4
|
|
ASX - By Stock
|
AVL |
Re:
Ann: Vanadium Electrolyte Facility Construction Complete
|
|
JB1975
|
67 |
27K |
8 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
67
|
27K
|
8
|
|
ASX - By Stock
|
AVZ |
Re:
DRC ELECTION TODAY AVZ concerns
|
|
JB1975
|
514 |
196K |
8 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
514
|
196K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Taken up the entitlement?
|
|
JB1975
|
544 |
129K |
2 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
544
|
129K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First USA site initiated in aGvHD trial
|
|
JB1975
|
31 |
7.9K |
5 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
31
|
7.9K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First USA site initiated in aGvHD trial
|
|
JB1975
|
31 |
7.9K |
2 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
31
|
7.9K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First USA site initiated in aGvHD trial
|
|
JB1975
|
31 |
7.9K |
3 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
31
|
7.9K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First USA site initiated in aGvHD trial
|
|
JB1975
|
31 |
7.9K |
1 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
31
|
7.9K
|
1
|
|